Taken together, our data demonstrated the protective role of miR-30c in cardiac metabolism in diabetes via targeting PGC-1β, and suggested that modulation of PGC-1β by miR-30c may provide a therapeutic approach for DCM. Here, PPARGC1B is linked to familial dilated cardiomyopathy.